Literature DB >> 24737742

Evidence for increased SOX3 dosage as a risk factor for X-linked hypopituitarism and neural tube defects.

Marijke Bauters1, Suzanna G Frints, Hilde Van Esch, Liesbeth Spruijt, Marcella M Baldewijns, Christine E M de Die-Smulders, Jean-Pierre Fryns, Peter Marynen, Guy Froyen.   

Abstract

Genomic duplications of varying lengths at Xq26-q27 involving SOX3 have been described in families with X-linked hypopituitarism. Using array-CGH we detected a 1.1 Mb microduplication at Xq27 in a large family with three males suffering from X-linked hypopituitarism. The duplication was mapped from 138.7 to 139.8 Mb, harboring only two annotated genes, SOX3 and ATP11C, and was shown to be a direct tandem copy number gain. Unexpectedly, the microduplication did not fully segregate with the disease in this family suggesting that SOX3 duplications have variable penetrance for X-linked hypopituitarism. In the same family, a female fetus presenting with a neural tube defect was also shown to carry the SOX3 copy number gain. Since we also demonstrated increased SOX3 mRNA levels in amnion cells derived from an unrelated t(X;22)(q27;q11) female fetus with spina bifida, we propose that increased levels of SOX3 could be a risk factor for neural tube defects.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  SOX3 duplication; X-linked hypopituitarism; gene overexpression; growth hormone deficiency; neural tube defect

Mesh:

Substances:

Year:  2014        PMID: 24737742     DOI: 10.1002/ajmg.a.36580

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  9 in total

1.  Mir505-3p regulates axonal development via inhibiting the autophagy pathway by targeting Atg12.

Authors:  Kan Yang; Bin Yu; Cheng Cheng; Tianlin Cheng; Bo Yuan; Kai Li; Junhua Xiao; Zilong Qiu; Yuxun Zhou
Journal:  Autophagy       Date:  2017-08-18       Impact factor: 16.016

Review 2.  Genetics of Combined Pituitary Hormone Deficiency: Roadmap into the Genome Era.

Authors:  Qing Fang; Akima S George; Michelle L Brinkmeier; Amanda H Mortensen; Peter Gergics; Leonard Y M Cheung; Alexandre Z Daly; Adnan Ajmal; María Ines Pérez Millán; A Bilge Ozel; Jacob O Kitzman; Ryan E Mills; Jun Z Li; Sally A Camper
Journal:  Endocr Rev       Date:  2016-11-09       Impact factor: 19.871

Review 3.  Genome annotation for clinical genomic diagnostics: strengths and weaknesses.

Authors:  Charles A Steward; Alasdair P J Parker; Berge A Minassian; Sanjay M Sisodiya; Adam Frankish; Jennifer Harrow
Journal:  Genome Med       Date:  2017-05-30       Impact factor: 11.117

4.  Congenital hypopituitarism in two brothers with a duplication of the 'acrogigantism gene' GPR101: clinical findings and review of the literature.

Authors:  Melitza S M Elizabeth; Annemieke J M H Verkerk; Anita C S Hokken-Koelega; Joost A M Verlouw; Jesús Argente; Roland Pfaeffle; Sebastian J C M M Neggers; Jenny A Visser; Laura C G de Graaff
Journal:  Pituitary       Date:  2020-11-13       Impact factor: 4.107

Review 5.  Maternal folic acid and multivitamin supplementation: International clinical evidence with considerations for the prevention of folate-sensitive birth defects.

Authors:  R D Wilson; D L O'Connor
Journal:  Prev Med Rep       Date:  2021-10-25

6.  Comparative Genomic Hybridization to Microarrays in Fetuses with High-Risk Prenatal Indications: Polish Experience with 7400 Pregnancies.

Authors:  Katarzyna Kowalczyk; Magdalena Bartnik-Głaska; Marta Smyk; Izabela Plaskota; Joanna Bernaciak; Marta Kędzior; Barbara Wiśniowiecka-Kowalnik; Marta Deperas; Justyna Domaradzka; Alicja Łuszczek; Daria Dutkiewicz; Agata Kozar; Dominika Grad; Magdalena Niemiec; Kamila Ziemkiewicz; Róża Magdziak; Natalia Braun-Walicka; Artur Barczyk; Maciej Geremek; Jennifer Castañeda; Anna Kutkowska-Kaźmierczak; Paweł Własienko; Krystyna Jakubów-Durska; Marzena Dębska; Anna Kucińska-Chahwan; Szymon Kozłowski; Boyana Mikulska; Tadeusz Issat; Tomasz Roszkowski; Agnieszka Nawara-Baran; Agata Runge; Anna Jakubiuk-Tomaszuk; Anna Kruczek; Ewa Kostyk; Grzegorz Pietras; Janusz Limon; Jerzy Zwoliński; Karolina Ochman; Tomasz Szajner; Piotr Węgrzyn; Mirosław Wielgoś; Maria Sąsiadek; Ewa Obersztyn; Beata Anna Nowakowska
Journal:  Genes (Basel)       Date:  2022-04-14       Impact factor: 4.141

7.  Studies of mice deleted for Sox3 and uc482: relevance to X-linked hypoparathyroidism.

Authors:  Katie U Gaynor; Irina V Grigorieva; Samantha M Mirczuk; Sian Piret; Kreepa G Kooblall; Mark Stevenson; Karine Rizzoti; Mike R Bowl; M Andrew Nesbit; Paul T Christie; William D Fraser; Tertius Hough; Michael P Whyte; Robin Lovell-Badge; Rajesh Thakker
Journal:  Endocr Connect       Date:  2020-01-01       Impact factor: 3.335

8.  Copy Number Variants Contributing to Combined Pituitary Hormone Deficiency.

Authors:  Bartłomiej Budny; Katarzyna Karmelita-Katulska; Marek Stajgis; Tomasz Żemojtel; Marek Ruchała; Katarzyna Ziemnicka
Journal:  Int J Mol Sci       Date:  2020-08-11       Impact factor: 5.923

9.  Xq26.3-q27.1 duplication including SOX3 gene in a Chinese boy with hypopituitarism: case report and two years treatment follow up.

Authors:  Caiqi Du; Feiya Wang; Zhuoguang Li; Mini Zhang; Xiao Yu; Yan Liang; Xiaoping Luo
Journal:  BMC Med Genomics       Date:  2022-02-03       Impact factor: 3.063

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.